Neprilysin inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9150500
SERIAL NO

14180479

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the invention relates to compounds having the formula:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THERAVANCE BIOPHARMA R&D IP, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fenster, Erik San Bruno, US 31 136
Fleury, Melissa San Francisco, US 108 1123
Gendron, Roland San Francisco, US 84 1151
Hughes, Adam D Belmont, US 108 1166
Moran, Edmund J San Francisco, US 65 934

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 6, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00